Concepta PLC Launch of myLotus app in China
20 February 2018 - 6:01PM
RNS Non-Regulatory
TIDMCPT
Concepta PLC
20 February 2018
20 February 2018
Concepta plc
("Concepta" or the "Company")
Launch of myLotus app in China
Concepta plc (AIM: CPT), the UK healthcare company and developer
of a proprietary product targeted at the mobile health market with
a primary focus on women's fertility, is pleased to announce that
it has signed an agreement with Beijing Jiayou Ltd, ("AppInChina")
to manage the distribution of its new myLotus app on Android
systems throughout China.
The free app, which allows women to monitor and track fertility,
can be used either as an individual fertility tracker or in
conjunction with the myLotus monitor.
Through AppInChina, Concepta will focus on distribution of the
app through the top 5 Chinese Android app stores, which between
them have a market share of around 75.7%* of the Android app
market. This includes Tencent's Myapp, the leading Chinese app
store, which holds a 25.1%* market share of the Android app
distribution coverage in China.
In addition, the myLotus app is also currently available on the
Chinese iOS app store, which has a 13% smartphone market share in
China.
Erik Henau, CEO of Concepta commented: "The myLotus app is an
extremely useful resource for women trying to conceive. Not only is
it effective as a stand-alone resource, but in conjunction with our
myLotus meter, it is a powerful tool to allow women with
unexplained infertility to conceive naturally. It enables women who
are struggling to conceive to monitor their ovulation cycle more
effectively than standard home testing kits. The combination of
both the app and the myLotus meter will enhance the consumer
experience and the product proposition, as well as increasing
awareness of the product."
"As the only app with a direct link to qualitative and
quantitative results of a woman's personal hormone levels, it
provides women with a platform to build an accurate conception
diary, which will assist them and their partner during the process
of conception."
* Newzoo - "Top 10 android app stores"
https://newzoo.com/insights/rankings/top-10-android-app-stores-china/
Enquiries:
The Company
Erik Henau
CEO
Tel: +44 (0) 1234 866601
SPARK Advisory Partners Limited (Nomad)
Neil Baldwin / Mark Brady
Tel: +44 (0)20 368 3550
NOVUM Securities Limited (Broker)
Colin Rowbury
+44 (0) 20 7399 9400
Yellow Jersey (Financial PR)
Georgia Colkin / Joe Burgess / Katie Bairsto
Tel: +44 (0) 776 932 5254
About Concepta Plc:
Concepta plc is an AIM-quoted pioneering UK healthcare company
that has developed a proprietary product, myLotus, targeted at the
personalised mobile health market with a primary focus on
unexplained infertility* in women.
myLotus is currently the only consumer product which allows both
quantitative and qualitative measurements of a woman's personal LH
and hCG* hormone levels in a home test, facilitating higher
conception rates and early diagnosis of issues with fertility
hormones. The proposition of myLotus is to help women conceive
naturally.
Concepta has made significant progress recently, establishing
agreements with a number of distributors in China where myLotus has
been given cFDA approval. Concepta is initially targeting the
traditional route to market in China through Chinese hospitals and
plans to add the direct-to-consumer route in the near future.
The Company is also well on its way to achieving CE-marking and
commencing its direct-to-consumer launch in the UK and Europe in H1
2018. The Company has identified a significant global market
opportunity, with revenue potential of the Chinese and EU
unexplained infertility market estimated to be worth c.GBP600m per
annum.
*Unexplained infertility refers to women that have been unable
to conceive after 6 months of trying. This highly motivated target
group of consumers won't typically be offered medical intervention
until 12 months of unsuccessfully trying, with IVF not offered
until two years. Research indicates couples start to take positive
action ahead of this time and there is little medical support to
help them do so.
About RNS Reach announcements
RNS Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to
distribute media only / non-regulatory news releases such as
marketing messages, corporate and product information into the
public domain. An RNS Regulatory announcement is required to be
notified under the AIM Rules for Companies.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAFKCDBDBKBCBD
(END) Dow Jones Newswires
February 20, 2018 02:01 ET (07:01 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024